(The following press release from Bayer was received by e-mail. It was not 
confirmed by the sender.)  
Bayer CropScience expands cooperation with Brazilian wheat-breeding company
Monheim, March 4, 2013 - Bayer CropScience and the Brazilian wheat-breeding
company Biotrigo Genetica Ltda. have signed an agreement to expand their
successful cooperation. With this agreement, Bayer will be able to use the
lineage of new wheat varieties of one of Brazil’s leading wheat breeding
companies. Biotrigo’s germplasm pool is renowned for its yield, high
milling and baking quality and disease resistance. Financial details were
not disclosed. 
"Our agreement with Biotrigo is another step towards a world-class research
platform for wheat genetics," said Hartmut van Lengerich, Head of Cereals
and Fungicides at Bayer CropScience. "We have entered into collaborations
with the best partners in wheat research and breeding across the world. Now
we are also looking forward to working with the motivated and experienced
Biotrigo team." 
"Biotrigo is a global leader in combining grain yield and end-use quality
with resistance to difficult-to-control diseases," said Edward Souza,
Director of Wheat Breeding at Bayer CropScience. "Their guidance will help
us continue to build our capacity in Europe and emerging markets." 
For André Rosa, Biotrigo Business Director, the agreement with Bayer
CropScience is important because it strengthens the company's growth and
contributes to its vision of leadership in Latin America. 
According to Ottoni Rosa Filho, Biotrigo Technical Director, the agreement
will enable an even greater investment in research and development,
contributing to generations of innovation for wheat farmers. "This
agreement enables Biotrigo and its partners to be more competitive by
enhancing their portfolio of cultivars in the medium and long-term,"
assured Ottoni Rosa Filho. 
According to André Rosa, Bayer CropScience is synonymous with quality in
everything it does. "This agreement with one of the most successful and
respected agricultural companies in the world thanks to its brand and
solutions shows that the quality of research at Biotrigo is being
Biotrigo is based in Passo Fundo in the region Rio Grande do Sul in
southern Brazil. Both companies are already involved in a successful
cooperation for the joint development of customized solutions consisting of
wheat seeds and crop protection products for the Brazilian market. The
expansion of this collaboration is focused on regions outside the Americas. 
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health
care, agriculture and high-tech materials. This year the company looks back
on 150 years of working to fulfill its mission "Bayer: Science For A Better
Life". Bayer CropScience, the subgroup of Bayer AG responsible for the
agricultural business, has annual sales of EUR 8,383 million (2012) and is
one of the world’s leading innovative crop science companies in the areas
of seeds, crop protection and non-agricultural pest control. The company
offers an outstanding range of products including high value seeds,
innovative crop protection solutions based on chemical and biological modes
of action as well as an extensive service backup for modern, sustainable
agriculture. In the area of non-agricultural applications, Bayer
CropScience has a broad portfolio of products and services to control pests
from home and garden to forestry applications. The company has a global
workforce of 20,800 and is represented in more than 120 countries. This and
further news is available at: 
About Biotrigo
Biotrigo is a Brazilian wheat breeding company, located in Passo Fundo, Rio
Grande do Sul, with a focus on development of wheat cultivars for Brazil
and other Latin American countries. The company has three breeding
programs, which have been delivering superior seeds to the wheat market
over the years. The cultivars developed by Biotrigo are a result of more
than 20 years of research. Its seeds are recognized as of high yield
associated with breadmaking quality and resistance to diseases. Find more
information at: 
Note to editors:
A photo in print quality can be downloaded from the internet at and 
Find more information at 
Forward-Looking Statements
This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results, financial
situation, development or performance of the company and the estimates
given here. These factors include those discussed in Bayer’s public reports
which are available on the Bayer website at The
company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments. 
This press release is available here: 
Yours BayNews Editorial Team 
Bayer AG
Building W11
51368 Leverkusen, Germany 
Further news releases you can find here: 
N.B. This is an automatically generated e-mail which you cannot reply to.
If you have any questions, please send us an e-mail via our contact form: 
You can cancel your subscription to the BayNews-Newsletter or change your
personal settings at any time by going to 
To ensure receipt, please add to your
address book or list of trusted senders. 
© Bayer AG, 51368 Leverkusen, Germany. 
All rights reserved. The entire contents, including images, graphics,
animations etc., of this e-mail and the server are
Board of Management: Marijn Dekkers, Chairman | Werner Baumann, Wolfgang
Plischke, Richard Pott
Chairman of the Supervisory Board: Werner Wenning
Registered office: Leverkusen | Local Court  of Cologne, HRB 48248
Press spacebar to pause and continue. Press esc to stop.